Rucaparib: A Promising PARP Inhibitor in Ovarian a..

새 기사를 만들었습니다

6 디

Rucaparib: A Promising PARP Inhibitor in Ovarian and Prostate Cancer Treatment | #rucaparib Wholesaler

Rucaparib: A Promising PARP Inhibitor in Ovarian and Prostate Cancer Treatment

Rucaparib: A Promising PARP Inhibitor in Ovarian and Prostate Cancer Treatment

Rucaparib is approved for the treatment of women with advanced ovarian cancer who have received two or more lines of chemotherapy and whose tumors exhibit BRCA mutations.

처럼

논평

공유하다